biotech
-
BiotechCorp, Quintiles collaborate
Quintiles solidified the partnership with BiotechCorp, signifying interests in the areas of shared services central laboratory and biobank, clinical research graduate/internship training program, stem cell research and national vaccine hub.
biotech | 02 April 2012
-
Leukocare receives Frost & Sullivan’s biotechnology investment opportunity award
Leukocare has been awarded 2011’s Biotechnology Investment Opportunity Award by Frost & Sullivan.
biotech | 30 March 2012
-
MabCure signs license agreement with Biotech Investment Corp
MabCure has signed a license agreement with Biotech Investment Corp. (Biotech), a Nevada-based biotechnology investment company. The agreement is an exclusive worldwide license to certain MabCure hybridoma clones producing antibodies against prostate cancer. In addition to the license fee paid to MabCure, Biotech will issue to MabCure 15 percent of its outstanding shares on a fully diluted basis and will pay a royalty of 12.5 percent on revenues.
biotech | 07 February 2012
-
Sartorius Stedim Biotech, Refine Technology announce cooperation
This joint development project proactively responds to the current market demand for more effective connectivity between equipment from different suppliers to enable development of efficient, streamlined systems.
biotech | 26 January 2012
-
Pharmaceutical and biotech companies boost resources in medical affairs affiliates
Cutting Edge Information finds country-level medical affairs budgets now average $1.9 million.
biotech | 18 October 2011
-
PBS Biotech selects GCMS as exclusive bioreactor distributor in Korea
PBS Biotech Inc announced it has signed an exclusive distribution agreement in Korea with Green Cross Medical Sciences Corp (GCMS), one of Korea’s largest pharmaceutical firms. Under terms of the agreement GCMS will market, sell and support the com…
biotech | 27 July 2011
-
Biotechnology industry faces R&D challenges
Growing funding chasm between established players and early stage start-ups.
biotech | 15 July 2011
-
Biotechnology industry faces R&D challenges
Growing funding chasm between established players and early stage start-ups. The global biotechnology industry delivered solid top and bottom-line growth in 2010, with the industry achieving aggregate profitability for the second year in a row. Y…
biotech | 01 July 2011
-
New biotechnology firm, Caerus Discovery, launched
Company using proprietary methods for drug target discovery and antibody development.
biotech | 02 June 2011
-
Sequella, Maxwell Biotech Venture sign agreement on SQ109 for tuberculosis
Deal valued at over $100 million to the parties.
biotech | 26 April 2011
